Xie X, Tu J, You H, & Hu B. (2017). Design, synthesis, and biological evaluation of novel EF24 and EF31 analogs as potential IκB kinase β inhibitors for the treatment of pancreatic cancer. Dove Medical Press.
Chicago Style (17th ed.) CitationXie X, Tu J, You H, and Hu B. Design, Synthesis, and Biological Evaluation of Novel EF24 and EF31 Analogs as Potential IκB Kinase β Inhibitors for the Treatment of Pancreatic Cancer. Dove Medical Press, 2017.
MLA (9th ed.) CitationXie X, et al. Design, Synthesis, and Biological Evaluation of Novel EF24 and EF31 Analogs as Potential IκB Kinase β Inhibitors for the Treatment of Pancreatic Cancer. Dove Medical Press, 2017.
Warning: These citations may not always be 100% accurate.